Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus
- 2 November 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 37 (3), 683-690
- https://doi.org/10.1007/s10067-017-3893-1
Abstract
Exposure to fine particles may trigger pulmonary inflammation/systemic inflammation. The objective of this study was to investigate the association between daily individual exposure to air pollutants and airway inflammation and disease activity in childhood-onset systemic lupus erythematosus (cSLE) patients. A longitudinal panel study was carried out in 108 consecutive appointments with cSLE patients without respiratory diseases. Over four consecutive weeks, daily individual measures of nitrogen dioxide (NO2), fine particulate matter (PM2.5), ambient temperature, and humidity were obtained. This cycle was repeated every 2.5 months along 1 year, and cytokines of exhaled breath condensate-EBC [interleukins (IL) 6, 8, 17 and tumoral necrose factor-α (TNF-α)], fractional exhaled NO (FeNO), and disease activity parameters were collected weekly. Specific generalized estimation equation models were used to assess the impact of these pollutants on the risk of Systemic Lupus Erythematous Disease Activity Index 2000 (SLEDAI-2K) ≥ 8, EBC cytokines, and FeNO, considering the fixed effects for repetitive measurements. The models were adjusted for inflammatory indicators, body mass index, infections, medication, and weather variables. An IQR increase in PM2.5 4-day moving average (18.12 μg/m3) was associated with an increase of 0.05 pg/ml (95% CI 0.01; 0.09, p = 0.03) and 0.04 pg/ml (95% CI 0.02; 0.06, p = 0.01) in IL-17 and TNF-α EBC levels, respectively. Additionally, a short-term effect on FeNO was observed: the PM2.5 3-day moving average was associated with a 0.75 ppb increase (95% CI 0.38; 1.29, p = 0.03) in FeNO. Also, an increase of 1.47 (95% CI 1.10; 1.84) in the risk of SLEDAI-2K ≥ 8 was associated with PM2.5 7-day moving average. Exposure to inhalable fine particles increases airway inflammation/pulmonary and then systemic inflammation in cSLE patients.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (13/21508-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302724/2011-7 and 472155/2012-1)
This publication has 41 references indexed in Scilit:
- Residential Traffic-Related Pollution Exposures and Exhaled Nitric Oxide in the Children’s Health StudyEnvironmental Health Perspectives, 2011
- Human exhaled breath analysisAnnals of Allergy, Asthma & Immunology, 2011
- Determination of response of real-time SidePak AM510 monitor to secondhand smoke, other common indoor aerosols, and outdoor aerosolJournal of Environmental Monitoring, 2011
- Associations between Ambient Fine Particulate Levels and Disease Activity in Patients with Systemic Lupus Erythematosus (SLE)Environmental Health Perspectives, 2011
- The effect of ambient air pollution on exhaled nitric oxide in the Children's Health StudyEuropean Respiratory Journal, 2010
- The effects of chronic exposure to traffic derived air pollution on the ocular surfaceEnvironmental Research, 2010
- Tumor necrosis factor alpha as a marker of systemic and local inflammation in “healthy” smokersInternational Journal of General Medicine, 2009
- Systemic Inflammation, Endothelial Dysfunction, and Activation in Clinically Healthy Children Exposed to Air PollutantsInhalation Toxicology, 2008
- Personal and Ambient Air Pollution is Associated with Increased Exhaled Nitric Oxide in Children with AsthmaEnvironmental Health Perspectives, 2006
- Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 yearsJournal of Allergy and Clinical Immunology, 2005